| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.9B | $3.8B | $3.9B | $3.6B | $0.9B | $1.0B | $1.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.7B | $1.7B | $1.7B | $1.6B | $1.5B | $0.3B | $0.4B | $0.5B |
| Operating Income | $-0.0B | $-0.8B | $-0.8B | $0.1B | $0.2B | $0.1B | $0.2B | $0.4B |
| Net Income | $-0.5B | $-1.0B | $-1.1B | $-0.3B | $-0.2B | $0.0B | $0.1B | $0.2B |
| EPS (Basic) | $-3.06 | $-6.68 | $-7.39 | $-1.79 | $-1.09 | $0.02 | $0.77 | $2.51 |
| EPS (Diluted) | $-3.06 | $-6.68 | $-7.39 | $-1.79 | $-1.09 | $0.02 | $0.77 | $2.51 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1B | $5.6B | $7.0B | $8.3B | $8.9B | $9.2B | $11.0B | $12.3B |
| Current Assets | $1.5B | $1.4B | $1.5B | $1.5B | $1.5B | $1.6B | $1.4B | $2.2B |
| Cash & Equivalents | $0.3B | $0.3B | $0.3B | $0.3B | $0.4B | $0.7B | $0.4B | $0.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.0B | $0.9B | $0.8B | $0.8B | $0.8B | $0.7B | $0.7B | $1.2B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.2B | $0.4B | $0.3B | $0.2B | $0.5B | $1.0B |
| Investing Cash Flow | $-0.1B | $0.0B | $-0.1B | $-0.1B | $-0.3B | $-0.1B | $-0.1B | $-0.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.3B |
| Financing Cash Flow | $-0.0B | $-0.2B | $-0.2B | $-0.3B | $-0.4B | $0.2B | $-0.1B | $-0.5B |